Physical Exercise for Colorectal Cancer Patients After Transanal Total Mesorectal Excision

NCT ID: NCT03120104

Last Updated: 2017-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-30

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fecal incontinence is common in patients with rectal cancer after surgery. Previous studies showed that pelvic floor muscle and external sphincter muscle training after stoma closure could improve the severity of incontinence and other fecal symptoms, but there is no study about the effects of pelvic floor muscle exercise intervention before stoma closure. We are wondering would the symptom of fecal incontinence recover sooner and better if we give the pelvic floor muscle exercise intervention before the stoma closure. This article aims at comparing the effects of pelvic floor muscle training before stoma closure on fecal incontinence (pre-intervention group) with pelvic floor muscle training after stoma closure (post-intervention group), and we hypothesise that the severity of fecal incontinence will improve sooner and better in pre-intervention group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-intervention group

Pre-intervention group interventions:pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just one month before the stoma closure

Group Type ACTIVE_COMPARATOR

pelvic floor muscle exercise before stoma closure

Intervention Type OTHER

pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just one month before the stoma closure

Post-intervention group

Post-intervention group: pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) two weeks after the stoma closure

Group Type ACTIVE_COMPARATOR

pelvic floor muscle exercise after stoma closure

Intervention Type OTHER

pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just two weeks after the stoma closure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pelvic floor muscle exercise before stoma closure

pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just one month before the stoma closure

Intervention Type OTHER

pelvic floor muscle exercise after stoma closure

pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just two weeks after the stoma closure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* rectal cancer patients who have received transanal total mesorectal excision(TaTME) surgery; 20\~75 years old

Exclusion Criteria

* terminal stage of cancer; unable to following orders due to poor cognitive condition; too weak to follow the experimental procedures; central nervous system lesions
Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University WanFang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pin Li

Role: PRINCIPAL_INVESTIGATOR

Rehabilitation Department of Taipei Municipal WanFang Hospitial (Managed by Taipei Medical University)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Municipal Wanfang Hospital (Managed by Taipei Medical University)

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pin Li

Role: CONTACT

+886-988-259-482

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pin Li

Role: primary

+886-988-259-482

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N201610007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.